Pliant Therapeutics (PLRX) Preferred Dividend Payments (2019 - 2020)
Pliant Therapeutics (PLRX) posted quarterly Preferred Dividend Payments of $11.0 million for Q1 2020, up 207.05% quarter-over-quarter from -$10.3 million in Q4 2019.
Pliant Therapeutics (PLRX) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Preferred Dividend Payments for 2 consecutive years, with $11.0 million the latest figure, recorded in Q1 2020.
- In Q1 2020, Preferred Dividend Payments changed N/A year-over-year to $11.0 million; the TTM figure through Mar 2021 stood at $2.1 million (down 39.28% YoY), while the FY2019 annual figure was -$6.2 million, changed N/A from the prior year.
- Preferred Dividend Payments grew to $11.0 million in Q1 2020 per PLRX's latest filing, from -$10.3 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $11.0 million in Q1 2020 and bottomed at -$10.3 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 11.03 Mn |
| Dec 31, 2019 | -10.30 Mn |
| Sep 30, 2019 | 1.38 Mn |
| Jun 30, 2019 | 1.36 Mn |